HENDERSON MICHAEL THOMAS (Chief Executive Officer) sold 7.3% of their position (80K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $10.60M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2026ACC: 0001104659-26-077426
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-80K
Net shares
Net seller
$10.60M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
80K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−80K
Price / share
$132.54
Trade value
$10.60M
% of position
7.3%
6/22/2026
1.10M→1.02M
Total
Net shares
−80K
Net value
-$10.60M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | S · Sale | −80K | $132.54 | $10.60M | 7.3% | 1.10M | 1.02M |
| Total | −80K | -$10.60M | ||||||
Derivative Transactions0
No derivative transactions reported